Terpene-enriched cannabinoid composition for treatment of male subjects

A method for treating a condition selected from the group consisting of androgen deficiency, infertility, urogenital or reproductive system infections and/or disorders and combinations thereof in a male subject diagnosed as suffering from said condition, the method comprising administering to the male subject a therapeutically effective amount of a composition comprising

• (i) at least one cannabinoid at a total concentration of at least 5% by weight, wherein said at least one cannabinoid comprises tetrahydrocannabinol (THC), and wherein at least 50% of said at least one cannabinoid is in decarboxylated form,
• (ii) at least two terpenes selected from the group consisting of thujone, pinene, limonene, cymene, caryophyllene, caryophyllene oxide, eucalyptol, terpineol, sabinene, carene, geraniol, camphor and citronellol at a total concentration of at least 0.5% by weight, and
• (iii) at least 5% by weight of a non-cannabinoid, non-terpene carrier,
• wherein the composition is provided in a delivery form selected from the group consisting of tablets, gel capsules, sublingual oils, edibles, cigarettes, vaporizer liquids, nasal preparations, and combinations thereof, and
• wherein a total amount of terpenes to a total amount of cannabinoids in said composition is from about 0.1:1 to about 0.5:1, and
• wherein said composition is produced by adding at least one isolated terpene to a cannabis extract.